ARIAD Pharmaceuticals (ARIA) Presents Data on Its Kinase Inhibitor Which Demonstrated Mechanism-Based Activity in Solid Tumors
Tweet Send to a Friend
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) presented results of studies on its investigational, multi-targeted kinase inhibitor – AP24534 – showing anti-tumor ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
